help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 16, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1049
A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/11/5954    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, F. L.
Right arrow Articles by Hume, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, F. L.
Right arrow Articles by Hume, R.

Submitted on May 13, 2005
Accepted on August 4, 2005

Serum thyroid hormones in preterm infants; associations with postnatal illnesses and drug usage

Fiona LR Williams, Simon A Ogston, Hans van Toor, Theo J Visser, and Robert Hume*

Community Health Sciences, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY Scotland UK; Maternal and Child Health Sciences, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY Scotland UK; Department of Internal Medicine, Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands; For a list of members see acknowledgements

* To whom correspondence should be addressed. E-mail: r.hume{at}dundee.ac.uk.

Context. Transient hypothyroxinaemia is common in infants <30 weeks gestation and is associated with neurodevelopmental deficits. Reductions in T4 and T3 levels with TSH unchanged are the key features of severe illness using surrogate indices of overall severity of illness but these do not inform the impact of individual disease conditions or drug usage.

Objective. To investigate the contribution of postnatal factors to the variations in serum levels of iodothyronines, TBG and TSH

Design. An infant cohort study (23-34 wk gestation; n = 780) between January 1998 and September 2001.

Setting. Eleven level III Scottish neonatal intensive care units.

Patients. Cohorts of infants delivered at 23-34 weeks gestation.

Main Outcome. Serum levels of iodothyronines, TBG and TSH at 7, 14, and 28 days adjusted for the potentially significant postnatal influences (n = 31).

Results. Serum levels of TSH, FT4, T3, T4 are variably but significantly associated with bacteraemia, endotracheal bacterial cultures, persistent ductus arteriosus, necrotising enterocolitis, cerebral ultrasonography changes, oxygen dependence at 28 days and the use of aminophylline, caffeine, dexamethasone, diamorphine and dopamine.

Conclusions. There are many more associations of postnatal factors with transient hypothyroxinaemia than had previously been considered in preterm infants. Alternative strategies should be considered for correction of hypothyroxinaemia rather than sole reliance on the direct therapy of hormone replacement. A more oblique preventative approach may be necessary through reduction in the incidence or severity of individual illness(es). Similarly alternatives to those drugs which interfere with the hypothalamic-pituitary-thyroid axis should be evaluated (e.g. other inotropics instead of dopamine).


Key words: thyroid • development • hypothyroxinaemia • preterm • diamorphine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society